PNPLA2 and fatty liver disease: Using genetic and chemical ablation studies in a HFD mouse model, overexpression of hepatic ATGL and HSL promoted fatty acid oxidation to reduce hepatic TG contents by 40–60% and ameliorated hepatic steatosis.